Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 21;26(39):6057-6073.
doi: 10.3748/wjg.v26.i39.6057.

Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease

Affiliations

Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease

Yin-Chen Wu et al. World J Gastroenterol. .

Abstract

Background: The activity staging of Crohn's disease (CD) in the terminal ileum is critical in developing an accurate clinical treatment plan. The activity of terminal ileum CD is associated with the microcirculation of involved bowel walls. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) can reflect perfusion and permeability of bowel walls by providing microcirculation information. As such, we hypothesize that DCE-MRI and DWI parameters can assess terminal ileum CD, thereby providing an opportunity to stage CD activity.

Aim: To evaluate the value of DCE-MRI and DWI in assessing activity of terminal ileum CD.

Methods: Forty-eight patients with CD who underwent DCE-MRI and DWI were enrolled. The patients' activity was graded as remission, mild and moderate-severe. The transfer constant (Ktrans), wash-out constant (Kep), and extravascular extracellular volume fraction (Ve) were calculated from DCE-MRI and the apparent diffusion coefficient (ADC) was obtained from DWI. Magnetic Resonance Index of Activity (MaRIA) was calculated from magnetic resonance enterography. Differences in these quantitative parameters were compared between normal ileal loop (NIL) and inflamed terminal ileum (ITI) and among different activity grades. The correlations between these parameters, MaRIA, the Crohn's Disease Activity Index (CDAI), and Crohn's Disease Endoscopic Index of Severity (CDEIS) were examined. Receiver operating characteristic curve analyses were used to determine the diagnostic performance of these parameters in differentiating between CD activity levels.

Results: Higher Ktrans (0.07 ± 0.04 vs 0.01 ± 0.01), Kep (0.24 ± 0.11 vs 0.15 ± 0.05) and Ve (0.27 ± 0.07 vs 0.08 ± 0.03), but lower ADC (1.41 ± 0.26 vs 2.41 ± 0.30) values were found in ITI than in NIL (all P < 0.001). The Ktrans, Kep, Ve and MaRIA increased with disease activity, whereas the ADC decreased (all P < 0.001). The Ktrans, Kep, Ve and MaRIA showed positive correlations with the CDAI (r = 0.866 for Ktrans, 0.870 for Kep, 0.858 for Ve, 0.890 for MaRIA, all P < 0.001) and CDEIS (r = 0.563 for Ktrans, 0.567 for Kep, 0.571 for Ve, 0.842 for MaRIA, all P < 0.001), while the ADC showed negative correlations with the CDAI (r = -0.857, P < 0.001) and CDEIS (r = -0.536, P < 0.001). The areas under the curve (AUC) for the Ktrans, Kep, Ve, ADC and MaRIA values ranged from 0.68 to 0.91 for differentiating inactive CD (CD remission) from active CD (mild to severe CD). The AUC when combining the Ktrans, Kep and Ve was 0.80, while combining DCE-MRI parameters and ADC values yielded the highest AUC of 0.95.

Conclusion: DCE-MRI and DWI parameters all serve as measures to stage CD activity. When they are combined, the assessment performance is improved and better than MaRIA.

Keywords: Crohn’s disease; Diffusion-weighted imaging; Ileum; Magnetic resonance imaging; Perfusion imaging.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
A 41-year-old male with moderate active Crohn’s disease in the terminal ileum and a Crohn’s Disease Activity Index of 267 and Crohn’s Disease Endoscopic Index of Severity of 12. A: Terminal ileum demonstrates wall thickening and increased signal on axial T2-weighted image; B: Terminal ileum wall has a high signal. Axial diffusion-weighted imaging image (b = 800 s/mm2) demonstrates high signal (arrow) in the same bowel segment. Region of interest (ROI) for the inflammatory bowel wall shows that apparent diffusion coefficient = 1.11×10-3 mm2/s; C: ROI for the inflammatory bowel wall shows that Ktrans = 0.10 min-1 (Kep = 0.87 min-1, Ve = 0.11); D: In contrast, ROI of the normal appearing ileal loop shows that Ktrans = 0.01 min-1 (Kep = 0.80 min-1, Ve = 0.02); E: The contrast concentration curve of inflammatory bowel is plotted as ROI (line with circle) and fitted with the model (line); F: The contrast concentration curve of normal loop is plotted as ROI (line with circle) and fitted with the model (line). ROI: Region of interest.
Figure 2
Figure 2
A 42-year-old male with remission of Crohn’s disease in the terminal ileum and a Crohn’s Disease Activity Index of 108 and Crohn’s Disease Endoscopic Index of Severity of 2. A: Axial T2-weighted image shows mural thickening and hyperintensity in the terminal ileum (arrow); B: Axial diffusion-weighted imaging image (b = 800 s/mm2) demonstrates high signal (arrow) in the same bowel segment. Regions of interest (ROI) for the inflammatory bowel wall shows that apparent diffusion coefficient = 1.89×10-3 mm2/s; C: Ktrans map is obtained through the relevant phase. The perfusion parameters of the ROI placed in the terminal ileum is calculated by TCM (Ktrans = 0.18 min-1); D: Kep map is obtained through the relevant phase. The Kep of the ROI placed is 0.98 min-1; E: Ve map is obtained through the relevant phase. The Ve of the ROI placed is 0.19; F: The contrast concentration curve is plotted as ROI (line with circle) and fitted with the model (line). ROI: Region of interest.
Figure 3
Figure 3
The Ktrans, Kep, Ve and apparent diffusion coefficient among the three groups. A: Bar charts show increasing Ktrans, between the normal ileal loop (NIL) and the inflamed terminal ileum (ITI) and pairwise comparisons of them is different (all P < 0.001); B: Kep between the NIL and the ITI is different (all P < 0.001); C: Ve between the NIL and the ITI is different (all P < 0.001); D: Apparent diffusion coefficient between the NIL and the ITI is different (all P < 0.001). Furthermore, increasing Ktrans, Kep and Ve are shown with activity of CD in remission, mild and moderate-severe CD while decreasing apparent diffusion coefficients are shown (all P < 0.001). aP indicate difference with P < 0.001. NIL: Normal ileal loop; ITI: Inflamed terminal ileum.
Figure 4
Figure 4
Correlations of inflamed terminal ileum with Crohn’s Disease Activity Index and Crohn’s Disease Endoscopic Index of Severity in Crohn’s disease. A and C: Scatterplots show positive correlation of Ktrans, Kep and Ve and negative correlation of apparent diffusion coefficient in inflamed terminal ileum of Crohn’s disease patients with Crohn’s Disease Activity Index score; B and D: Positive correlation of Ktrans, Kep and Ve and negative correlation of apparent diffusion coefficient in inflamed terminal ileum of Crohn’s disease patients with Crohn’s Disease Endoscopic Index of Severity score. CDAI: Crohn’s Disease Activity Index; CDEIS: Crohn’s Disease Endoscopic Index of Severity; ADC: Apparent diffusion coefficient.
Figure 5
Figure 5
Receiver operating characteristic curve analysis. Receiver operating characteristic curve analysis shows high accuracy of Ktrans (areas under the curve [AUC] = 0.76), Ve (AUC = 0.78), Kep (AUC = 0.68), apparent diffusion coefficient (AUC = 0.89) and Magnetic Resonance Index of Activity (AUC = 0.91) for differentiating inactive from active Crohn’s disease. Accuracy of combining the Ktrans, Kep and Ve (AUC = 0.80) is higher than the individual dynamic contrast-enhanced magnetic resonance imaging parameters. The highest AUC is observed when combining dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging parameters (AUC = 0.95). ROC: Receiver operating characteristic; ADC: Apparent diffusion coefficient; DCE-MRI: Dynamic contrast-enhanced magnetic resonance imaging; MaRIA: Magnetic Resonance Index of Activity.
Figure 6
Figure 6
Bland-Altman analysis for the intraclass and interclass coefficients. A: Bland-Altman analysis of the difference between the two observers’ average results for Ktrans; B: Bland-Altman analysis of the difference between the two observers’ average results for apparent diffusion coefficient; C: Bland-Altman analysis of the difference between the two observers’ average results for Kep. ADC: Apparent diffusion coefficient; SD: Standard deviation.

Similar articles

Cited by

References

    1. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–297. - PubMed
    1. Kwak MS, Kim DH, Park SJ, Kim TI, Hong SP, Kim WH, Cheon JH. Efficacy of early immunomodulator therapy on the outcomes of Crohn's disease. BMC Gastroenterol. 2014;14:85. - PMC - PubMed
    1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV Jr, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5A–36A. - PubMed
    1. Magro F, Portela F, Lago P, Ramos de Deus J, Vieira A, Peixe P, Cremers I, Cotter J, Cravo M, Tavares L, Reis J, Gonçalves R, Lopes H, Caldeira P, Ministro P, Carvalho L, Azevedo L, da Costa-Pereira A GEDII. Crohn's disease in a southern European country: Montreal classification and clinical activity. Inflamm Bowel Dis. 2009;15:1343–1350. - PubMed
    1. Hart L, Bessissow T. Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease. Best Pract Res Clin Gastroenterol. 2019;38-39:101616. - PubMed